1. Human Parainfluenza Virus Infection after Hematopoietic Stem Cell Transplantation: Risk Factors, Management, Mortality, and Changes over Time 
Celalettin Ustun, Jiří Slabý, Ryan M. Shanley, Jan Vydra, Angela R. Smith, John E. Wagner, Daniel J. Weisdorf, Jo-Anne H. Young 
Biology of Blood and Marrow Transplantation 
Volume 18, Issue 10, Pages (October 2012)
DOI: /j.bbmt
Copyright © 2012 American Society for Blood and Marrow Transplantation Terms and Conditions

2. Figure 1
Frequency of human parainfluenza virus (HPIV) infections per season.
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2012 American Society for Blood and Marrow Transplantation Terms and Conditions

3. Figure 2 Trends of infection characteristics over time.
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2012 American Society for Blood and Marrow Transplantation Terms and Conditions

4. Figure 3
Incidence of human parainfluenza virus (HPIV) by year and conditioning intensity.
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2012 American Society for Blood and Marrow Transplantation Terms and Conditions

5. Figure 4
(A) Lower respiratory tract infection (LRTI) with human parainfluenza virus (HPIV) is associated with higher mortality than upper respiratory tract infection (URTI). (B) Higher mortality with early onset (<30 days) of LRT-HPIV. (C) Effect of antiviral treatment for LRT-HPIV on survival. Abbreviations: IVIG = intravenous immune globulin.
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2012 American Society for Blood and Marrow Transplantation Terms and Conditions